VIRAL SAFETY ISSUES - PLASMA-DERIVED FACTOR-VIII

被引：2

作者：

BERNTORP, E

机构：

[1] Coagulation Laboratory, Malmö Allmänna Sjukhus, Malmö

来源：

ANNALS OF HEMATOLOGY | 1994年 / 68卷

关键词：

D O I：

10.1007/BF01774528

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S35 / S36

页数：2

共 50 条

[1] INHIBITOR QUESTIONS - PLASMA-DERIVED FACTOR-VIII AND RECOMBINANT FACTOR-VIII
BRAY, G
ANNALS OF HEMATOLOGY, 1994, 68 : S29 - S34
[2] THE PHARMACOKINETICS AND VIRAL SAFETY OF A NEW PLASMA-DERIVED FACTOR-VIII CONCENTRATE, KOATE-HP
ROUSELL, RH
ABILDGAARD, CF
BROCKWAY, WJ
DOBKIN, MB
HARRISON, J
HEIN, R
PAPPENHAGEN, AR
SANCHEZ, LH
THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 211 - 211
[3] HEPATITIS-A VIRAL SAFETY OF PLASMA-DERIVED FACTOR-VIII CONCENTRATE KOATE(R)-HP
MITRA, G
DOBKIN, M
DUMAS, M
NG, P
ROLDAN, G
GALLOWAY, C
VOX SANGUINIS, 1994, 67 : 80 - 82
[4] Viral safety of plasma-derived factor VIII and IX concentrates
Ludlam, CA
BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 : S19 - S23
[5] RELATION OF ACTIVATED FACTOR-VIII TO THE POTENCY IN FACTOR-VIII CONCENTRATES, COMPARISON OF PLASMA-DERIVED AN RECOMBINANT FACTOR-VIII
MINAMIYAMA, T
ITO, Y
OGURI, S
KOBAYASHI, K
TAKEDA, M
THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 942 - 942
[6] RECENT ADVANCES IN THE PREPARATION OF PLASMA-DERIVED AND RECOMBINANT COAGULATION FACTOR-VIII
BRAY, GL
JOURNAL OF PEDIATRICS, 1990, 117 (03): : 503 - 507
[7] Factor VIII safety: plasma-derived versus recombinant products
Gringeri, Alessandro
BLOOD TRANSFUSION, 2011, 9 (04) : 366 - 370
[8] VIRAL SAFETY OF FACTOR-VIII CONCENTRATES
FOSTER, PR
VOX SANGUINIS, 1994, 66 (03) : 248 - 248
[9] RECOMBINANT AND PLASMA-DERIVED FACTOR-VIII ARE IMMUNOLOGICALLY DISTINCT IN IN-VITRO ASSAYS
GILLES, JGG
SAINTREMY, JMR
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1213 - 1213
[10] Why plasma-derived factor VIII?
Aledort, Louis
Carpenter, Shannon L.
Cuker, Adam
Kulkarni, Roshni
Recht, Michael
Young, Guy
Leissinger, Cindy
HAEMOPHILIA, 2019, 25 (03) : E183 - E185

← 1 2 3 4 5 →